+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Bone Grafts & Substitutes Market (2022-2027) by Type, Product, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 176 Pages
  • March 2022
  • Region: United States
  • Infogence Global Research
  • ID: 5585590
UP TO OFF until Dec 31st 2023
The US Bone Grafts & Substitutes Market is estimated to be USD 664.1 Mn in 2022 and is projected to reach USD 936.67 Mn by 2027, growing at a CAGR of 7.12%.

Market dynamics are forces that impact the prices and behaviors of the US Bone Grafts & Substitutes Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The US Bone Grafts & Substitutes Market is segmented based on Type, and Product.
  • By Type, the market is classified into Synthetic Bone Graft, Xenograft, Allograft, Autograft, Alloplast, Demineralized Allograft, and Others.
  • By Product, the market is classified into Bio OSS, Osteograf, and Grafton.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AlloSource, Anand Mediproducts, Arthrex
Baxter International, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the US Bone Grafts & Substitutes Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the US Bone Grafts & Substitutes Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the US Bone Grafts & Substitutes Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the US Bone Grafts & Substitutes Market

What is the estimated value of the US Bone Grafts & Substitutes Market?

The US Bone Grafts & Substitutes Market was estimated to be valued at $664.1 Million in 2022.

What is the growth rate of the US Bone Grafts & Substitutes Market?

The growth rate of the US Bone Grafts & Substitutes Market is 7.1%, with an estimated value of $936.67 Million by 2027.

What is the forecasted size of the US Bone Grafts & Substitutes Market?

The US Bone Grafts & Substitutes Market is estimated to be worth $936.67 Million by 2027.

Who are the key companies in the US Bone Grafts & Substitutes Market?

Key companies in the US Bone Grafts & Substitutes Market include AlloSource, Arthrex, Baxter International, Biohorizons Implant Systems, Geistlich Pharma, Medtronic, Nobel Biocare, Nuvasive, Orthofix Holdings and RTI Surgical.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Incidence of Musculoskeletal Disorders
4.1.2 Technological Advancements in Medical Field Leading to a Shift from Autograft to Allograft
4.2 Restraints
4.2.1 Higher Costs of Surgeries
4.3 Opportunities
4.3.1 Increasing Focus on R&D Activities in Bone Grafts & Their Substitutes
4.3.2 Upsurge in Demand for Orthopedic Procedures among Geriatric Population
4.4 Challenges
4.4.1 Ethical Issues Related to Bone Grafting Procedures
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 US Bone Grafts & Substitutes Market, By Type
6.1 Introduction
6.2 Synthetic Bone Graft
6.3 Xenograft
6.4 Allograft
6.5 Autograft
6.6 Alloplast
6.7 Demineralized Allograft
6.8 Others
7 US Bone Grafts & Substitutes Market, By Product
7.1 Introduction
7.2 Bio OSS
7.3 Osteograf
7.4 Grafton
8 Competitive Landscape
8.1 Competitive Quadrant
8.2 Market Share Analysis
8.3 Strategic Initiatives
8.3.1 M&A and Investments
8.3.2 Partnerships and Collaborations
8.3.3 Product Developments and Improvements
9 Company Profiles
9.1 AlloSource
9.2 Arthrex
9.3 Baxter International
9.4 Biohorizons Implant Systems
9.5 Geistlich Pharma
9.6 Medtronic
9.7 Nobel Biocare
9.8 Nuvasive
9.9 Orthofix Holdings
9.10 RTI Surgical
9.11 SeaSpine Holdings
9.12 SigmaGraft
9.13 Smith & Nephew
9.14 Stryker
9.15 Wright Medical Group
9.16 Zimmer Biomet
10 Appendix
10.1 Questionnaire

Companies Mentioned

  • AlloSource
  • Arthrex
  • Baxter International
  • Biohorizons Implant Systems
  • Geistlich Pharma
  • Medtronic
  • Nobel Biocare
  • Nuvasive
  • Orthofix Holdings
  • RTI Surgical
  • SeaSpine Holdings
  • SigmaGraft
  • Smith & Nephew
  • Stryker
  • Wright Medical Group
  • Zimmer Biomet